Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aim</h3><p>Recently, accumulating evidence has revealed strong association between intestinal microbiota alteration and inflammatory bowel disease (IBD). <i>Fusobacterium (F.) nucleatum </i> is a gram‐negative anaerobe. A multicenter cohort study reported that <i>F. nucleatum </i> was enriched in newly diagnosed IBD patients. Here, we aimed to explore the pathogen of IBD and its pathogenic mechanism. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Several bacteria associated with IBD or colorectal cancer were measured in fecal samples of 91 IBD patients and 43 healthy people. Mice with dextran sulfate sodium (DSS)‐induced colitis and Caco‐2 model system were used to explore the pathogenicity of <i>F. nucleatum </i>. Barrier damage was evaluated by transmission electron microscope, permeability of fluorescein isothiocyanate‐dextran, transepithelial electrical‐resistance and immunofluorescence. Protein level of cell–cell junction and activation of STAT3 signaling pathway were detected by immunohistochemistry and immunoblot. Cytokines secretion and T cell differentiation were measured by quantitative real‐time polymerase chain reaction and flow cytometry. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p><i>F. nucleatum </i> was significantly enriched in feces of IBD patients and its abundance was correlated with patients' disease activity. Administration of <i>F. nucleatum </i> markedly exacerbates colitis in DSS mice model. Mechanistically, <i>F. nucleatum </i> damaged epithelial integrity and increased permeability by regulating the expression and distribution of tight junction proteins ZO‐1 and occludin. Moreover, <i>F. nucleatum </i> promoted secretion of cytokines (TNF‐α, IFN‐γ, IL‐1β, IL‐6, and IL‐17), activated STAT3 signaling pathway, and induced proliferation of CD4<sup>+</sup>T cell and differentiation of Th1 and Th17 subsets. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our finding suggests that <i>F. nucleatum </i> could damage intestinal barrier and induce aberrant inflammation, which exacerbate colitis. </p><p>This article is protected by copyright. All rights reserved.</p></section>

Fusobacterium nucleatum Accelerates the Progression of Colitis-Associated Colorectal Cancer by Promoting EMT

Fusobacterium Nucleatum Subspecies Animalis Influences Proinflammatory Cytokine Expression and Monocyte Activation in Human Colorectal Tumors.

Fusobacterium Nucleatum Promotes the Progression of Colorectal Cancer by Interacting with E-cadherin.

Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer

Fusobacterium nucleatum exacerbates colitis by damaging epithelial barrier and inducing aberrant inflammation.

<i>Fusobacterium nucleatum</i> promotes colorectal cancer metastasis by modulating <i>KRT7-AS</i>/KRT7

Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β‐catenin modulator Annexin A1

Fusobacterium nucleatum Aggravates the Progression of Colitis by Regulating M1 Macrophage Polarization via AKT2 Pathway

Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality

Fusobacterium nucleatum -induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer

Fusobacterium nucleatum Promotes Metastasis in Colorectal Cancer by Activating Autophagy Signaling via the Upregulation of CARD3 Expression

Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.

Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis

FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2

Fusobacterium nucleatum and its metabolite hydrogen sulfide alter gut microbiota composition and autophagy process and promote colorectal cancer progression

Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS /KRT7.

Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation

Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation

The Role of Fusobacterium nucleatum in Oral and Colorectal Carcinogenesis

Detection of Fusobacterium nucleatum in Patients with Colitis-Associated Colorectal Cancer

The Role of Fusobacterium nucleatum in Colorectal Cancer Cell Proliferation and Migration